Skip To Content
ResearchOur PeopleAmanda Petrik

Amanda F. Petrik, PhD

Amanda Petrik, PhD, is a health services researcher with extensive training in social and health systems and policy. Dr. Petrik has more than 25 years of experience conducting research and over a decade implementing and evaluating cancer prevention programs in diverse practice settings, including in community clinics. Her research now focuses on Learning Health Systems, cancer prevention, and the use of predictive analytics in cancer prevention.

Dr. Petrik joined CHR in 2001. In 2021, she earned her PhD in health systems and policy from the OHSU-PSU School of Public Health in Portland. Dr. Petrik currently works on projects implementing a multilevel intervention to increase awareness of human papillomavirus (HPV) vaccination in school-based health centers (PEER, R01 NIMHD), increasing HPV vaccination in rural communities (PREVENT, R01, NCI), and implementing a self-collected cervical cancer screening program (STEP-2, UH3 NCI). She also leads work in patient engagement, and implementation projects focused on screening for chronic kidney disease.

Selected Current Studies

  • Self-Testing for Cervical Cancer in Priority Populations (The STEP-2 Trial; NCI)
  • Multilevel Peer-to-Peer HPV Vaccination and Wellness Education Program in School Based Health Centers (PEER; NIMHD)
  • Practice-based Approaches to Promote HPV Vaccination in the Safety Net (PREVENT; NCI)
  • Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity (PRIME; NIMHD)
  • Assessing the Long-Term Impacts of the COVID-19 Pandemic on Disparities in Cancer Screening and Follow-Up (RESTORE; NCI)

Selected Publications

  • Petrik AF, Johnson ES, Mummadi R, Slaughter M, Coronado GD, Lin SC, Savitz L, Wallace N. The use of individual and multilevel data in the development of a risk prediction model to predict patients’ likelihood of completing colorectal cancer screening. doi: 10.1016/j.pmedr.2023.102366. PMID: 37732019 PMCID: PMC10507149
  • Petrik AF, Coury J, Larson JH, Badicke B, Coronado GD, Davis MM. Data Challenges in Identifying Patients Due for Colorectal Cancer Screening in Rural Clinics. J Am Board Fam Med. 2023 Feb 8;36(1):118-129. doi: 10.3122/jabfm.2022.220216R1. PMID: 36759133 PMCID: PMC10187985
  • Petrik AF, Green B, Schneider J, Miech EJ, Coury J, Retecki S, Coronado GD. Factors Influencing Implementation of a Colorectal Cancer Screening Improvement Program in Community Health Centers: An Applied Use of Configurational Comparative Methods. J Gen Intern Med 2020 Nov;35(Suppl 2):815-822. doi: 10.1007/s11606-020-06186-2. Epub 2020 Oct 26. PMID: 33107003 PMCID: PMC7652967
  • Petrik AF, Keast E, Johnson ES, Smith DH, Coronado GD. Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics. BMC Health Serv Res 2020 Nov 10;20(1):1028. PMCID: PMC7654150
  • Petrik AF, Le T, Keast E, Rivelli J, Bigler K, Green B, Vollmer WM, Coronado G. Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers. J Community Health 2018 Feb;43(1):128-136. doi: 10.1007/s10900-017-0395-7. PMID: 28744716 PMCID: PMC5767531
  • Petrik AF, Green BB, Vollmer WM, Le T, Bachman B, Keast E, Rivelli J, Coronado GD. The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics. Fam Pract 2016 Dec;33(6):639-643. doi: 10.1093/fampra/cmw065. Epub 2016 Jul 28. PMID: 27471224 PMCID: PMC5161488
  • Coronado GD, Petrik AF, Slaughter M, Kepka D, Naleway AL. Adolescents who have undergone HPV vaccination are more likely to get a COVID-19 vaccination. J Adolesc Health. 2023 Jun;72(6):985-988. doi: 10.1016/j.jadohealth.2022.12.022. Epub 2023 Feb 11. PMID: 36781325 PMCID: PMC9918864
  • Coronado GD, Petrik AF, Vollmer WM, Taplin SH, Keast EM, Fields S, Green BB. Effectiveness of a Mailed Colorectal Cancer Screening Outreach Program in Community Health Clinics: The STOP CRC Cluster Randomized Clinical Trial. JAMA Intern Med 2018 Sep 1;178(9):1174-1181. doi: 10.1001/jamainternmed.2018.3629. PMID: 30083752 PMCID: PMC6142956
  • Davis MM, Schneider JL, Petrik AF, Miech EJ, Younger B, Escaron AL, Rivelli JS, Thompson JH, Nyongesa D, Coronado GD. Clinic Factors Associated with Mailed Fecal Immunochemical Test (FIT) Completion: The Difference-Making Role of Support Staff. Ann Fam Med 2022 Mar-Apr;20(2):123-129. doi: 10.1370/afm.2772. PMID: 35346927 PMCID: PMC8959740
  • Kuntz JL, Smith DH, Petrik AF, Yang X, Thorp ML, Barton T, Barton K, Labreche M, Spindel SJ, Johnson ES. Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship Efforts. Perm J 2016 Winter;20(1):20-5. doi: 10.7812/TPP/15-049. PMID: 26845084 PMCID: PMC4732790

Follow Us

Copyright © 2026, Kaiser Permanente Center for Health Research

Kaiser Permanente identifies financial conflicts of interest (FCOI) and other situations that may give rise to conflicts of interest, and addresses such situations to ensure research decisions made are in the best interests of KP, its research participants, patients, and members. Kaiser Permanente operates in accordance with federal regulations addressing research financial conflicts of interest through our Policy on FCOI in Research.